Page last updated: 2024-11-04

gatifloxacin and Eperythrozoonosis

gatifloxacin has been researched along with Eperythrozoonosis in 3 studies

Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCarthy, KL1
Looke, DF1
Hamasuna, R1
Takahashi, S1
Kiyota, H1
Yasuda, M1
Hayami, H1
Arakawa, S1
Tomono, K1
Matsumoto, T1
Pereyre, S1
Renaudin, H1
Bébéar, C1
Bébéar, CM1

Trials

1 trial available for gatifloxacin and Eperythrozoonosis

ArticleYear
Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial.
    Sexually transmitted infections, 2011, Volume: 87, Issue:5

    Topics: Adult; Aged; Anti-Infective Agents; Drug Administration Schedule; Fluoroquinolones; Gatifloxacin; Hu

2011

Other Studies

2 other studies available for gatifloxacin and Eperythrozoonosis

ArticleYear
Successful treatment of post-neurosurgical intracranial Mycoplasma hominis infection using gatifloxacin.
    The Journal of infection, 2008, Volume: 57, Issue:4

    Topics: Adolescent; Anti-Bacterial Agents; Brain Abscess; Female; Fluoroquinolones; Gatifloxacin; Humans; Ma

2008
In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

    Topics: Anti-Infective Agents; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Microbial Sensitivity T

2004